Aspirin reduces CRC growth via different mechanisms such as, inhibition of cyclooxygenase-2, dysregulation of NFκβ and Wnt-β-catenin signalling pathways, activation of EGFR pathway, host immune response modulation and up-regulation of tumour suppression genes [61–63]. This evidence concerns the gene EGFR and colorectal carcinoma.